BIVDA Press Releases

15Jan

BIVDA response to Parliament’s vote on the Brexit deal

Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.

Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”

For a copy of BIVDA's position paper on Brexit, click here.

Related

BIVDA Unveils New Website

The British In Vitro Diagnostics Association (BIVDA) has today unveiled its new website including a ...

Read More >

BIVDA Response to the Life Sciences Sector Deal

Commenting on the publication of the Life Sciences Sector Deal (6th December 2017), BIVDA’s Chief E...

Read More >

BIVDA and Diabetes UK call for urgent action on blood glucose monitoring

BIVDA and Diabetes UK are calling for healthcare professionals (HCPs) to take urgent action and chec...

Read More >

BIVDA comment on the Health and Social Care Committee’s report into Antimicrobial resistance

Today the Health and Social Care Committee has published its report on Antimicrobial resistance.

Read More >

IVD Industry Launches 2017 General Election Manifesto

Increasing the adoption of in vitro diagnostics (IVDs) should be a priority for the next Government,...

Read More >

BIVDA Launches Vision for Increasing Access to Molecular Diagnostics

A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...

Read More >